Condition: Pulmonary Arterial Hypertension (PAH) · Sponsor: Regeneron Pharmaceuticals
This study is researching an experimental drug called REGN13335. The study is focused on participants with Pulmonary Arterial Hypertension (PAH). The aim of the study is to see how safe and effective REGN13335 is in participants with PAH who are taking other PAH medicines. The study is looking at several other research questions, including: * What side effects may happen from taking REGN13335 * How much REGN13335 is in the blood at different times * Whether the body makes antibodies against REGN13335 (which could make REGN13335 less effective or could lead to side effects)
This description comes directly from the study's public registry record.
Clinical Trials Administrator · 844-734-6643 · clinicaltrials@regeneron.com
Always discuss trial participation with your own doctor first.
| University of Colorado Denver | Aurora, Colorado, United States | Recruiting |
| Mater Misericordiae Ltd | South Brisbane, Queensland, Australia | Recruiting |
| Royal Hobart Hospital | Hobart, Tasmania, Australia | Recruiting |
| UZ Leuven | Leuven, Vlaams-Brabant, Belgium | Recruiting |
| H.U.B. Erasme Hospital | Brussels, Belgium | Recruiting |
| Hopital Bicetre | Le Kremlin-Bicêtre, France | Recruiting |
| Universitatsklinikum Halle | Halle, Saxony-Anhalt, Germany | Recruiting |
| Clinic of University Greifswald | Greifswald, Germany | Recruiting |
| Universitatsmedizin Mainz | Mainz, Germany | Recruiting |
| P. Stradins Clinical University hospital | Riga, Latvia | Recruiting |
| University Clinical Hospital in Poznan - Early Phase Unit | Poznan, Greater Poland Voivodeship, Poland | Recruiting |
| University Hospital in Bialystok | Bialystok, Podlaskie Voivodeship, Poland | Recruiting |
+ 12 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07318597